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Abstract: Almost every cell of the human body is constantly exposed to DNA damaging agents of
exogenous and endogenous origin, which can cause various lesions in the genome. These DNA damages can
have mutagenic potential and lead to genomic instability that is one of the major drivers of carcinogenesis.
To deal with DNA alterations, cells have developed highly specialized DNA repair pathways. Two distinct
mechanisms, termed non-homologous end joining (NHEJ) and homologous recombination (HR), deal
with repair of DNA double- strand breaks (DSBs), the most dangerous form of DNA damages. HR is
an accurate repair mechanism, but it is restricted to S and G2 phases of the cell cycle. On the other
hand, NHEJ can take place throughout the cell cycle and is error-prone. HR reaction relies on an
initial 5’ to 3’ DNA end resection step generating 3’ ssDNA overhangs. In yeast, the Exonuclease 1 and
the helicase/nuclease Dna2 in conjunction with the RecQ-type helicase Sgs1 constitute two independent
pathways for long-range DNA-end resection. In human cells, there are five RecQ homologs known, namely
RECQL1, BLM, WRN, RECQL4 and RECQL5. It has already been demonstrated that human BLM can
mediate DNA-end resection in conjunction with DNA2. However, data obtained from a study in Xenopus
egg extracts identified WRN as the major helicase that works in complex with DNA2 to catalyse DNA-
end resection. Therefore, we wanted to investigate whether WRN can mediate DNA-end resection in
conjunction with DNA2 in human cells. Within this thesis work it is demonstrated that indeed WRN
can promote DNA2-mediated DNA end processing and that this process is dependent on the presence of
RPA and ATP. In addition, this reaction occurs in 5’ to 3’ direction generating the anticipated 3’ ssDNA
overhang required for HR repair. Further, we provide evidence for the physical interaction of WRN and
DNA2 in vitro and in vivo. Moreover, we found that WRN and BLM stimulate extensive DNA end
resection by DNA2 in vivo. Finally, we show that BLM mediates DNA-end resection as part of the BLM-
TOPOIII￿-RMI1-RMI2 (BTRR) complex. Taken together our data provide evidence that in human cells,
DNA2 resects broken DNA ends in conjunction with either WRN or BTRR complex. The 3’ ssDNA tail
generated by DNA-end resection is subsequently coated with RPA and does not only serve as a substrate
for the loading of RAD51 recombinase, but also provides a platform for the activation of ATR kinase that
is recruited to RPA-coated ssDNA trough its interacting protein ATRIP. Activated ATR phosphorylates
CHK1 thereby inducing the DNA damage checkpoint that leads to a cell cycle stop. Although previous
studies show that MutS￿, a heterodimeric mismatch repair protein composed of MSH2 and MSH3, is
involved in the HR process, its exact function is unclear. In this thesis work, it is demonstrated that MutS￿
serves as a mediator in ATR activation upon DNA DSB induction in human cells. We provide evidence
that MSH2, MSH3 and ATR/ATRIP form a complex in cells. In addition, we show that siRNA-mediated
depletion of MSH2 or MSH3 impairs the phosphorylation of ATR targets and the formation of ATRIP
foci in response to replication- associated DNA DSBs. Further, mutations in the mismatch-binding
domain of MSH3 diminished the binding of MutS￿ to persistent hairpin loops in RPA-coated ssDNA and
compromised ATR activation in vivo. Thus, our results demonstrate that MutS￿ binds to hairpin loop
structures persisting in RPA-coated ssDNA at sites of DNA damage and mediates recruitment of the ATR-
ATRIP complex for its activation. HR has the potential to generate chromosomal rearrangements trough
crossover formation. While crossovers are required in meiotic cells for proper chromosome segregation, in
mitotic cells, HR predominantly proceeds via the synthesis-dependent strand annealing (SDSA) pathway
that always leads to non-crossover products. This implies that mitotic cells possess a stringent control
system for HR subpathway selection. However the underlying molecular mechanism is not well defined.
Here, we present evidence that siRNA- mediated knockdown of RECQ5 impairs DNA DSB repair by
SDSA in human cells. Further, we provide in vivo and in vitro data demonstrating that RECQ5 helicase
counteracts the inhibitory effect of RAD51 on RAD52-mediated ssDNA annealing, a key step of SDSA.
Finally, we show that RECQ5 suppresses sister chromatid exchanges in human cells in a complementary
manner with the BTRR complex that mediates the dissolution of recombination intermediates to prevent
crossovers. These results suggest that RECQ5 acts during the post-synaptic phase of SDSA to prevent
formation of aberrant RAD51 filaments on the extended invading strand, thus limiting its channeling
into potentially hazardous crossover pathway. Taken together, the results of this thesis work identify new
key players and their exact working mechanism in the cellular response to DNA DSBs and thus provide
potential new therapeutic targets for cancer therapy.
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können.	 Diese	 DNS-Schäden	 sind	 potentiell	 mutagen	 und	 können	 zu	 einem	 instabilen	
Genom	führen,	einem	der	treibenden	Faktoren	für	die	Krebsentwicklung.	Um	solchen	DNS-
Veränderungen	 entgegenzuwirken,	 haben	 Zellen	 hochspezialisierte	 DNS-Reparatursysteme	
entwickelt.	 Zwei	 unterschiedliche	Mechanismen,	 bekannt	 als	 nicht-homologes	 End-Joining	
(NHEJ)	 und	 homologe	 Rekombination	 (HR),	 sind	 für	 die	 Reparatur	 von	 DNS-
Doppelstrangbrüchen	 zuständig,	 der	 gefährlichsten	 Form	 von	DNS-Schäden.	Die	HR	 ist	 ein	
sehr	genauer	Reparaturmechanismus,	 allerdings	 ist	 sie	beschränkt	auf	die	 S	und	G2-Phase	
des	 Zellzyklus.	 Dem	 gegenüber	 steht	 das	NHEJ,	welches	während	 des	 gesamten	 Zellzyklus	
stattfinden	kann,	jedoch	fehleranfällig	ist.	Um	sie	zu	initiieren,	benötigt	die	HR-Reaktion	eine	





bewiesen,	 dass	 das	menschliche	BLM	Protein	 im	Zusammenspiel	mit	DNA2	eine	DNS-End-
Resektion	 durchführen	 kann.	 Allerdings	 haben	 Daten	 aus	 einer	 Studie	 mit	 Xenopus-Eier	
Extrakten	 WRN	 als	 die	 wichtigste	 Helikase	 identifiziert,	 die	 in	 einem	 Komplex	 mit	 DNA2	
zusammenarbeitet,	 um	 die	 DNS-End-Prozessierung	 auszuführen.	 Daher	 wollten	 wir	
untersuchen,	 ob	 WRN	 und	 DNA2	 im	 Stande	 sind,	 zusammen	 die	 DNA-End-Resektion	 in	
menschlichen	Zellen	zu	verrichten.	 In	der	vorliegenden	Arbeit	 ist	gezeigt,	dass	WRN	 in	der	
Tat	 fähig	 ist,	 die	DNA2-abhängige	DNS-End-Resektion	 zu	 fördern,	 und	dass	 diese	Reaktion	
auf	 RPA	 und	 ATP	 angewiesen	 ist.	 Des	Weiteren	 findet	 dieser	 Prozess	 in	 5’	 zu	 3’-Richtung	
statt	 und	 generiert	 damit	 den	 erwarteten	 3’-Einzelstrang-DNS	 Überhang,	 der	 für	 die	 HR	
notwendig	 ist.	 Zusätzlich	 konnten	 wir	 zeigen,	 dass	 WRN	 und	 DNA2	 in	 vitro	 und	 in	 vivo	
miteinander	interagieren.	Ausserdem	haben	wir	herausgefunden,	dass	WRN	und	BLM	in	der	
Lage	 sind,	 die	 extensive	 DNS-End-Resektion,	 die	 durch	 DNA2	 ausgeführt	 wird,	 in	 vivo	 zu	
stimulieren.	 	 Schlussendlich	 haben	 wir	 demonstriert,	 dass	 BLM	 als	 Bestandteil	 des	 BLM-





Die	 DNS-End-Resektion	 generiert	 einen	 3’-Einzelstrang-DNS	 Überhang,	 der	
umgehend	von	RPA	ummantelt	wird	und	nicht	nur	als	Substrat	für	die	RAD51-Rekombinase	
dient,	 sondern	 auch	 als	 Plattform	 für	 die	Aktivierung	der	ATR-Kinase,	 die	 durch	ATRIP	 zur	
RPA-umhüllten	 Einzelstrang-DNS	 gebracht	 wird.	 Die	 aktivierte	 ATR-Kinase	 phosphoryliert	
CHK1	und	induziert	damit	einen	Kontrollmechanismus	für	DNS-Schäden,	der	umgehend	den	
Zellzyklus	 stoppt.	 Obwohl	 vorangehende	 Studien	 demonstriert	 haben,	 dass	 MutSβ,	 ein	
heterodimerisches	 Mismatch-Reparatur-Protein,	 bestehend	 aus	 MSH2	 und	 MSH3,	 im	 HR-
Mechanismus	 involviert	 ist,	 ist	seine	genaue	Funktion	nach	wie	vor	unklar.	 In	dieser	Arbeit	
wird	gezeigt,	dass	MutSβ	in	menschlichen	Zellen	als	Vermittler	in	der	ATR-Aktivierung	nach	
Formierung	 eines	 DNS-Doppelstranbruches	 dient.	 Wir	 beweisen	 ebenfalls	 die	
Proteinkomplexbildung	von		MSH2,	MSH3	und	ATR/ATRIP	in	menschlichen	Zellen.	Zusätzlich	
zeigen	wir,	dass	die	siRNS-gesteuerte	Elimination	von	MSH2	oder	MSH3	nach	der	Induktion	
eines	 Replikations-assoziierten	 DNS-Doppelstrangbruches	 die	 Phosphorylierung	 von	 ATR-
Zielproteinen	 und	 die	 Bildung	 von	 ATRIP-Fokuspunkten	 verhindert.	 Des	 Weiteren	 haben	
Mutationen	 in	 dem	 Mismatch-bindenden	 Teil	 von	 MSH3	 die	 Bindung	 von	 MutSβ	 zu	
bleibenden	Haarnadel-Strukturen	in	der	RPA-ummantelten	DNS	verunmöglicht	und	die	ATR-
Aktivierung	 in	 vivo	 eingeschränkt.	 Demzufolge	 zeigen	 unsere	 Resultate,	 dass	 MutSβ	 an	
beständige	 Haarnadel-Strukturen	 in	 RPA-umhüllter	 Einzelstrang-DNS	 bindet	 und	 die	
Rekrutierung	und	Aktivierung	des	ATR-ATRIP-Komplexes	vermittelt.		
Die	HR	hat	das	Potential	eine	Umgestaltung	der	chromosomalen	Struktur	durch	die	
Formierung	 sogenannter	 Crossover	 auszulösen.	 Während	 diese	 Crossover	 in	 meiotischen	
Zellen	für	die	Anordnung	der	einzelnen	Chromosomen	unerlässlich	ist,	durchläuft	die	HR	in	
mitotischen	 Zellen	 vorzugsweise	 den	 synthese-abhängigen	 Stang-Anlagerungs	 (SDSA)	
Mechanismus,	 der	 immer	 zu	 nicht-crossover	 Reparaturprodukten	 führt.	 Daraus	 lässt	 sich	
schliessen,	 dass	 mitotische	 Zellen	 ein	 sehr	 strenges	 Kontrollsystem	 für	 die	 Auswahl	 der	
einzelnen	 HR-Subreaktionen	 besitzen.	 Allerdings	 ist	 über	 den	 molekularen	 Mechanismus,	
der	 diesem	 System	 zugrunde	 liegt,	 nicht	 sehr	 viel	 bekannt.	 Hier	 ist	 gezeigt,	 dass	 in	
menschlichen	Zellen	die	siRNS-gesteuerte	Elimination	des	RECQ5-Proteins	die	Reparatur	von	
DNS-Doppelstrangbrüchen	 durch	 den	 SDSA-Weg	 vermindert.	 Die	 RAD52-vemittelte	 DNS-
Einzelstrang-Anlagerung	 ist	 ein	 fundamentaler	 Schritt	 des	 SDSA-Mechanismus,	 und	 wir	
Zusammenfassung	
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konnten	 beweisen,	 dass	 RECQ5	 dem	 inhibitorischen	 Effekt	 von	 RAD51	 auf	 diesen	 Prozess	
entgegenwirkt.	 Abschliessend	 demonstrieren	 wir,	 dass	 RECQ5	 den	 Austausch	 von	
Schwestrchromatid-Abschnitten	 verhindert	 und	 dadurch	 den	 BTRR	 Komplex	 ergänzt,	
welcher	 die	 Auflösung	 von	 HR-Zwischenprodukten	 katalysiert,	 um	 die	 Bildung	 von	
Crossovern	 zu	 vermindern.	 Unsere	 Resultate	 zeigen	 an,	 dass	 RECQ5	 während	 der	 post-
synaptischen	 Phase	 des	 SDSA-Mechanismus	 aktiv	 ist,	 um	 die	 Formierung	 von	 anomalen	
RAD51-Filamenten	auf	dem	neu	 synthetisierten,	 invasiven	DNS-Strang	 zu	unterbinden	und	
dadurch	einschränkt,	dass	die	Reparatur	den	riskanten	Crossover-Mechanismus	durchläuft.		
Zusammengefasst	 identifizieren	 die	 Resultate	 der	 vorliegenden	 PhD-Arbeit	 neue	





Almost	 every	 cell	 of	 the	 human	 body	 is	 constantly	 exposed	 to	 DNA	 damaging	 agents	 of	
exogenous	 and	 endogenous	origin,	which	 can	 cause	 various	 lesions	 in	 the	 genome.	 These	
DNA	damages	can	have	mutagenic	potential	and	 lead	 to	genomic	 instability	 that	 is	one	of	
the	 major	 drivers	 of	 carcinogenesis.	 To	 deal	 with	 DNA	 alterations,	 cells	 have	 developed	
highly	specialized	DNA	repair	pathways.	Two	distinct	mechanisms,	termed	non-homologous	
end	 joining	 (NHEJ)	 and	 homologous	 recombination	 (HR),	 deal	with	 repair	 of	 DNA	 double-





independent	 pathways	 for	 long-range	 DNA-end	 resection.	 In	 human	 cells,	 there	 are	 five	
RecQ	 homologs	 known,	 namely	 RECQL1,	 BLM,	WRN,	 RECQL4	 and	 RECQL5.	 It	 has	 already	




DNA2	 in	 human	 cells.	 Within	 this	 thesis	 work	 it	 is	 demonstrated	 that	 indeed	 WRN	 can	
promote	 DNA2-mediated	 DNA	 end	 processing	 and	 that	 this	 process	 is	 dependent	 on	 the	
presence	of	RPA	and	ATP.	In	addition,	this	reaction	occurs	in	5’	to	3’	direction	generating	the	
anticipated	3’	ssDNA	overhang	required	for	HR	repair.	Further,	we	provide	evidence	for	the	
physical	 interaction	of	WRN	and	DNA2	 in	vitro	and	 in	vivo.	Moreover,	we	found	that	WRN	
and	BLM	stimulate	extensive	DNA	end	resection	by	DNA2	in	vivo.	Finally,	we	show	that	BLM	
mediates	 DNA-end	 resection	 as	 part	 of	 the	 BLM-TOPOIIIα-RMI1-RMI2	 (BTRR)	 complex.	
Taken	 together	our	data	provide	evidence	 that	 in	human	 cells,	DNA2	 resects	 broken	DNA	
ends	in	conjunction	with	either	WRN	or	BTRR	complex.	
	 The	3’	ssDNA	tail	generated	by	DNA-end	resection	 is	subsequently	coated	with	RPA	
and	 does	 not	 only	 serve	 as	 a	 substrate	 for	 the	 loading	 of	 RAD51	 recombinase,	 but	 also	
provides	a	platform	for	the	activation	of	ATR	kinase	that	 is	recruited	to	RPA-coated	ssDNA	




that	 MutSβ,	 a	 heterodimeric	 mismatch	 repair	 protein	 composed	 of	 MSH2	 and	 MSH3,	 is	
involved	 in	 the	 HR	 process,	 its	 exact	 function	 is	 unclear.	 In	 this	 thesis	 work,	 it	 is	
demonstrated	that	MutSβ	serves	as	a	mediator	in	ATR	activation	upon	DNA	DSB	induction	in	
human	cells.	We	provide	evidence	that	MSH2,	MSH3	and	ATR/ATRIP	form	a	complex	in	cells.	
In	 addition,	 we	 show	 that	 siRNA-mediated	 depletion	 of	 MSH2	 or	 MSH3	 impairs	 the	
phosphorylation	of	ATR	targets	and	the	formation	of	ATRIP	foci	 in	response	to	replication-
associated	 DNA	 DSBs.	 Further,	 mutations	 in	 the	 mismatch-binding	 domain	 of	 MSH3	
diminished	 the	 binding	 of	 MutSβ	 to	 persistent	 hairpin	 loops	 in	 RPA-coated	 ssDNA	 and	
compromised	 ATR	 activation	 in	 vivo.	 Thus,	 our	 results	 demonstrate	 that	 MutSβ	 binds	 to	
hairpin	loop	structures	persisting	in	RPA-coated	ssDNA	at	sites	of	DNA	damage	and	mediates	
recruitment	of	the	ATR-ATRIP	complex	for	its	activation.	
	 HR	 has	 the	 potential	 to	 generate	 chromosomal	 rearrangements	 trough	 crossover	
formation.	 While	 crossovers	 are	 required	 in	 meiotic	 cells	 for	 proper	 chromosome	
segregation,	in	mitotic	cells,	HR	predominantly	proceeds	via	the	synthesis-dependent	strand	




provide	 in	 vivo	 and	 in	 vitro	 data	 demonstrating	 that	 RECQ5	 helicase	 counteracts	 the	
inhibitory	effect	of	RAD51	on	RAD52-mediated	ssDNA	annealing,	a	key	step	of	SDSA.	Finally,	
we	 show	 that	 RECQ5	 suppresses	 sister	 chromatid	 exchanges	 in	 human	 cells	 in	 a	
complementary	 manner	 with	 the	 BTRR	 complex	 that	 mediates	 the	 dissolution	 of	
recombination	 intermediates	 to	prevent	crossovers.	These	results	suggest	 that	RECQ5	acts	
during	 the	post-synaptic	phase	of	SDSA	to	prevent	 formation	of	aberrant	RAD51	 filaments	
on	 the	 extended	 invading	 strand,	 thus	 limiting	 its	 channeling	 into	 potentially	 hazardous	
crossover	pathway.	






The	 adult	 human	 body	 is	 composed	 of	 approximately	 1013	 cells	 that	 can	 be	 divided	 into	
several	different	cell	types	forming	highly	structured	tissues	and	organs	[1].	Despite	the	fact	
that	 many	 cells	 are	 highly	 differentiated	 and	 fulfil	 distinct	 functions,	 they	 all	 contain	 the	
same	genetic	 information	and	originate	from	one	single	progenitor	cell.	Cell	division	 is	not	




case	of	 injuries.	Further,	meiosis,	which	 is	another	 type	of	cell	division,	 is	 fundamental	 for	
the	production	of	germ	cells.	Growth	and	division	of	cells	within	a	 tissue	 is	mediated	by	a	
variety	 of	 complex	 mechanisms	 involving	 intra-	 and	 extracellular	 signal	 transduction	
pathways.	Typically,	a	growth-	and	division-promoting	ligand	binds	to	a	cell	surface	receptor,	
for	 instance	 receptor-tyrosin	 kinases,	 triggering	 an	 intracellular	 response	 that	 leads	 to	 an	
increase	of	the	cell	size	and	activates	the	cell	division	cycle	[3].	In	healthy	tissues,	these	cell	
division-inducing	 signal	 molecules,	 also	 called	 mitogens,	 are	 highly	 regulated	 in	 their	
production	and	secretion	[3].	Thus,	cell	division	within	healthy	tissues	is	strictly	controlled.			
	 Cancer	 is	 a	 disease	 that	 is	 characterised	 by	 cells	 whose	 growth	 is	 out-of-control.	
More	 precisely,	 it	 is	 a	 group	 of	 diseases	 consisting	 of	 more	 than	 100	 different	 types	 of	




some	 cases,	 they	 even	 release	 hormones	 that	 can	 alter	 the	 function	 of	 the	 whole	 body.	
Tumours	should	not	be	seen	only	as	a	clump	of	cells	that	 is	proliferating	at	very	high	rate.	
They	 form	 complex	 tissues	 in	 conjunction	 with	 different	 non-neoplastic	 cell	 types.	 In	
extreme	cases,	like	the	Hodgkin's	lymphoma,	these	normal	cells	can	make	up	to	99%	of	the	
tumour	mass	[4].	Trough	heterotypic	interactions,	the	neoplastic	cells	communicate	with	the	






is	 usually	 limited,	malignant	 cells	 start	 to	 invade	 the	 neighbouring	 healthy	 tissues.	 Under	




causes	of	death,	cancer	might	 take	over	 this	position	 in	 the	near	 future	since	cancer	 is	an	
old-age	 disease	 and	 the	 expectancy	 of	 life	 is	 still	 increasing	 in	 industry	 nations	 [7,	 8].	 To	
understand	the	basic	principles	of	tumour	formation,	it	is	important	first	to	understand	the	
ongoing	processes	in	single	cells	that	can	lead	to	cancer	development.		
	 Hanahan	and	Weinberg	have	defined	 six	hallmarks	of	 cancer	 showing	 the	different	
capabilities	that	cells	may	have	to	acquire	during	their	evolution	from	normal	to	malignant	
tumour	cells	[9].	They	also	describe	that	development	of	cancerous	lesions	is	a	progressive	
process	 that	 passes	 trough	 several	 stages	 where	 these	 abilities	 are	 worked	 out	 [9].	 As	
already	mentioned	above,	cancer	cells	have	the	ability	to	proliferate	continuously,	which	is	
probably	 the	most	 fundamental	 hallmark	 in	 carcinogenesis	 (Figure	 1).	 They	 can	 do	 so	 by	
several	mechanisms.	One	possibility	is	that	cells	start	to	produce	mitogens	and	subsequently	
release	 them	 to	 stimulate	 their	 own	 surface	 receptors	 resulting	 in	 increased	 cell-division	
rates	 [10].	 Closely	 related	 to	 this	 action,	 the	 tumour-associated	 stroma	 cells	 can	 also	 be	




to	grow,	 there	are	 tumour	suppressor	proteins	working	 in	anti-proliferative	programs	 that	
have	 to	be	overcome	(Figure	1).	Such	a	protein	 is	p53	 that	 is	a	central	effector	and	 found	
frequently	 inactivated	 in	 many	 cancer	 types	 [13].	 This	 protein	 gets	 input	 signals	 from	
intracellular	stress-	and	damage	response	machineries	and	decides	whether	the	progression	
of	the	cell	cycle	should	be	stopped	to	allow	repair	or	whether	apoptosis	should	be	induced	
[14].	 Apoptosis,	 the	 programmed	 cell	 death,	 is	 an	 important	 component	 of	 the	 cellular	
response	to	prevent	carcinogenesis	(Figure	1)	[15,	16].	There	are	two	major	pathways	known	
to	 induce	 apoptosis	 in	 a	 cell,	 an	 extrinsic	 and	 an	 intrinsic	 one	 [17].	 The	 extrinsic	 program	
relies	 on	 an	 extracellular	 death-inducing	 signal	 by	 for	 instance	 Fas-ligand	 binding	 to	 its	
receptor	 activating	 an	 intracellular	 signal	 cascade	 [17].	 On	 the	 other	 hand,	 the	 intrinsic	
Introduction	
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apoptotic	 system	 is	 dependent	 on	 intracellular	 signals	 that	 are	 transduced	 by	 p53	 for	
instance	[18].	Both	apoptosis	pathways	peak	in	the	activation	of	the	same	effector	caspases	
that	 lead	 to	 dismantling	 of	 the	 cell	 [17].	 Cancer	 cells	 have	 established	methods	 to	 avoid	








it	 is	 still	 viable	 but	 does	 not	 divide	 anymore.	 Those	 cells	 that	 are	 able	 to	 bypass	 this	 first	
barrier	enter	the	crisis	phase,	a	second	arrest	phase	[22-24].	In	this	last	phase	usually	all	cells	
die	due	 to	 recurrent	 chromosome	bridge-breakage-fusion	cycles	 leading	 to	apoptosis	 [24].	
Nevertheless	 under	 some	 circumstances,	 they	 are	 able	 to	 escape	 and	 get	 unlimited	
replicative	 capability	 (Figure	 1)	 [3,	 22,	 23].	 This	 immortalization	 can	 be	 achieved	 by	 re-
expressing	telomerase,	an	enzyme	that	is	capable	of	re-extending	the	shortened	telomeres	
[24].	In	fact,	this	is	the	case	in	approximately	90%	of	malignant	tumours	[25].		




during	wound	healing	 [26].	 If	a	 tumour	expanded	up	 to	a	given	size,	hypoxia	and	nutrient	
starvation	induce	an	angiogenic	switch	(Figure	1)	[27].	This	mechanism	enables	tumour	cells	
to	 release	 factors	 like	 the	 vascular	 endothelial	 growth	 factor	 leading	 eventually	 to	
neovascularisation	of	the	tumour	tissue	[28].	In	contrast	to	the	highly	organised	network	of	
blood	 vessels	 in	 healthy	 tissues,	 tumour	 vasculature	 is	 unstructured,	 leaky	 and	 does	 not	
provide	 a	 continuous	 blood	 supply	 [29].	 This	 derives	 from	 the	 fact	 that	 angiogenesis	 in	 a	
tumour	 is	 constantly	 active	 and	 does	 not	 allow	 stabilization	 of	 the	 newly	 formed	 vessels	
[29].	
	 Probably	 the	 most	 devastating	 hallmark	 of	 cancer	 is	 the	 formation	 of	 metastases	





blood	 and	 lymphatic	 system	 by	 which	 they	 get	 transported	 throughout	 the	 body	 and	 at	
some	point	exit	the	vasculature	trough	a	process	called	extravasion	[30].	Next,	a	crucial	step	
is	 the	 survival	 of	 the	 mobile	 cell	 in	 a	 new	microenvironment	 at	 a	 distant	 location.	 Once	
adapted	 to	 the	new	conditions,	 the	migrated	 cell	 eventually	 grows	and	divides,	building	a	










promoting	 inflammation	 [3].	 It	 is	 well	 known	 that	 macrophages	 infiltrate	 tumours	 where	
they	rather	induce	further	tumour	progression	than	fight	against	the	cancer	cells	[33,	34].	On	
the	 other	 hand,	 tumour	 formation	 and	 progression	 is	 also	 driven	 by	 specific	mutations	 in	
two	 key	 gene	 types	 called	 proto-oncogenes	 and	 tumour	 suppressor	 genes.	 A	 gain-of-
function	 mutation	 in	 proto-oncogenes	 turns	 them	 into	 oncogenes	 that	 enhance	 cell	







among	 many	 cancers	 are	 altered	 number	 of	 chromosomes	 due	 to	 chromosome	
missegregation	during	mitosis	 [36-38].	 Further,	 structural	 anomalies	of	 the	DNA	can	occur	
trough	 deletions,	 insertions	 or	 translocations	 of	 chromosome	 parts.	 In	 addition,	 single	
nucleotides	can	be	changed,	lost	or	inserted	[39].	Thus,	a	very	important	objective	for	every	




Different	 sources	 of	 endogenous	 and	 exogenous	 origin	 can	 cause	 the	 above-mentioned	
types	 of	 genomic	 instability	 (Figure	 2).	 In	 fact,	 a	 single	 human	 cell	 can	 receive	 several	
thousands	 of	 DNA	 lesions	 every	 day	 [40].	 DNA	 damage	 can	 arise	 from	 physiological	
processes	that	take	place	during	the	cell	cycle.	Reactive	oxygen	species	(ROS),	formed	by	the	
respiratory	 chain	 of	 the	 cells,	 are	 such	 genotoxic	 chemicals	 that	 can	 harm	 the	 genetic	
information	(Figure	2).	ROS	release	by	macrophages	and	neutrophils	is	part	of	the	immune	
response	to	fight	pathogens,	demonstrating	the	toxic	characteristics	of	these	molecules	[41,	
42].	Further,	polymerases	can	 introduce	mismatches	while	 replicating	 the	genome	or	DNA	
strand	breaks	can	occur	if	DNA	topoisomerase	function	is	impaired	(Figure	2)	[43].	While	the	






contain	 still	 sufficient	 amounts	 of	 energy	 to	 induce	 around	 105	 DNA	 alterations	 in	 every	
exposed	 cell	 per	hour	 [43].	 Ionizing	 radiation	 (IR),	 including	X-,	ϒ-,	α-,	 β-	 and	 cosmic-rays,	
also	harbours	mutation-inducing	potential	since	it	can	lead	to	DNA	lesions	like	DNA	double-
strand	breaks	(DSBs)	(Figure	2)	[47].	IR	is	generated	for	instance	by	the	radioactive	decay	of	
radionuclides	 or	 is	 used	 in	medical	 examinations	 while	 X-raying	 a	 patient.	 The	 danger	 to	
human	health	 that	emanates	 from	excessive	exposure	to	 IR	has	been	underlined	after	 the	













DNA	 bases	 and	 are	 thus	 mutagenic.	 Consistent	 with	 their	 characteristics,	 it	 has	 been	
demonstrated	that	these	toxins	can	induce	the	formation	of	liver	cancer	[51-53].	
	 Some	 aromatic	 chemicals	 like	 ethidium	 bromide,	 which	 are	 frequently	 used	 in	





	 Particular	 genotoxic	 agents	 can	 also	 induce	 the	 formation	 of	 DNA	 single-strand	
breaks	(SSBs)	(Figure	2).	 If	this	DNA	lesion	is	 left	unrepaired,	the	replication	machinery	can	
collide	with	it	resulting	in	the	formation	of	DNA	DSBs.	Two	SSBs	that	are	located	closely	lead	
to	 the	 same	 effect.	 It	 is	 well	 known	 that	 DNA	 DSBs	 are	 highly	 cytotoxic	 and,	 if	 left	
unrepaired,	can	 lead	to	chromosomal	rearrangements	or	cell	death	[58,	59].	Nevertheless,	
DNA	DSBs	are	also	generated	on	purpose	in	V(D)J	recombination	of	maturating	B-	and	T-cells	
[60].	 In	 addition,	 the	 Spo11	 enzyme	 actively	 generates	 DNA	 DSBs	 during	 meiotic	
recombination	[61].	
	 To	 counteract	 DNA	 damage	 and	 the	 above-mentioned	 consequences	 that	 would	
come	along	with	 it,	cells	have	evolved	a	multiplicity	of	mechanisms,	collectively	 termed	as	
the	 DNA	 damage	 response	 (DDR)	 that	 recognises	 a	 DNA	 lesion,	 signals	 its	 presence	 and	
initiates	 sophisticated	 pathways	 resulting	 in	DNA	 repair	 (Figure	 2)	 [43,	 62].	Defects	 in	 the	







cause	distinct	DNA	 lesions	 that	 have	 to	be	 repaired	by	 specialised	DNA	 repair	 pathways	 to	 restore	 genomic	
integrity.	 Abbreviations:	 cis-Pt,	 cisplatin;	 MMC,	 mitomycin	 C;	 (6–4)PP,	 6–4	 photoproduct;	 CPD,	 cyclobutane	
pyrimidine	dimer;	HR,	homologous	recombination;	EJ,	end	joining.	Adapted	and	modified	from	[63].		
3.2. DNA	repair	Pathways			









DNA	helix-distorting	adducts,	 such	as	 those	generated	by	UV	 light	 (6-4	photoproducts	and	
pyrimidine	dimers),	are	eliminated	by	nucleotide	excision	repair	(NER)	that	is	split	 into	two	
sub-pathways:	transcription-coupled	NER	(TC-NER)	and	global	genome	NER	(GG-NER)	(Figure	
3)	 [64].	Both	pathways	are	mechanistically	akin,	however	 the	way	 in	which	 they	recognise	
the	 DNA	 lesion	 is	 different.	 While	 the	 GG-NER	 acts	 genome	 wide	 and	 checks	 for	 DNA	
distortions,	the	TC-NER	gets	activated	when	RNA-Polymerase	II	is	stuck	during	transcription	
because	of	 the	presence	of	DNA	damage.	 In	GG-NER,	 the	helix	distortion	 is	sensed	by	XPC	
binding	to	the	DNA	[65,	66].	Since	pyrimidine	dimers	cause	only	a	limited	destabilisation	of	
the	DNA,	initiation	of	the	pathway	is	assisted	by	XPE	and	DDB2	[67-70].	The	following	step	is	
the	 verification	 of	 the	 damage	 that	 is	 conducted	 by	 XPC-mediated	 binding	 of	 the	 TFIIH	
complex	 to	 the	 DNA	 [71].	 This	 transcription	 initiation	 and	 repair	 factor	 is	 composed	 of	
multiple	subunits	amongst	others,	the	XPB	and	XPD	helicases	[72].	These	proteins	are	able	to	
unwind	 the	 DNA	 around	 the	 lesion	 and	 have	 opposite	 polarities.	 However	 it	 has	 been	
demonstrated	 that	 rather	 the	 ATPase	 than	 the	 helicase	 activity	 of	 XPB	 is	 required	 for	
opening	 the	 DNA	 [73].	 The	 endonucleases	 XPF/ERCC1	 and	 XPG	 then	 cleave	 the	 damaged	
strand	5’	and	3’	 to	 the	damage,	 respectively,	 removing	a	stretch	of	22-30	nucleotides	 [74-
76].	RPA	binding	to	the	undamaged	strand	is	not	only	important	to	protect	it	from	damaging	
effects,	 but	 it	 is	 also	 required	 for	 positioning	 of	 the	 aforementioned	 nucleases	 [77].	




is	different	 (Figure	3)	 [75].	As	mentioned	above,	 if	RNA	Pol	 II	gets	stuck	on	a	 lesion	during	
transcription,	 recruitment	 of	 the	 CSA	 and	 CSB	 proteins	 leads	 to	 initiation	 of	 TC-NER	 [78].	
These	 proteins	 are	 crucial	 for	 the	 recruitment	 of	 other	 factors	 involved	 in	 TC-NER,	 the	







Figure	 3:	 Nucleotide	 excision	 repair	 system.	 There	 are	 two	 nucleotide	 excision	 repair	 pathways	 known	 as	














During	 replication	of	 the	 genome,	 errors	 can	occur	 in	 the	 form	of	 insertions,	 deletions	 or	
miss-incorporated	 nucleotides.	 Although	 the	 replicative	 polymerases	 δ	 and	 ε	 have	
proofreading	 function	 to	 check	 whether	 the	 inserted	 nucleotide	 is	 correct,	 it	 has	 been	
estimated	that	1	in	each	109	to	1010	base	pairs	is	mutated	per	cell	division	[81,	82].	To	detect	
and	 repair	 such	 mistakes,	 the	 mismatch	 repair	 (MMR)	 system	 continuously	 screens	 the	
newly	 synthesised	 strands	 [83].	 In	E.coli,	distinction	 between	 the	 template	 and	 the	 newly	
synthesised	strand	occurs	via	DNA	adenine	methylation	(Dam)	at	GATC	sites	[84].	Although	
the	MMR	mechanism	seems	to	be	evolutionarily	conserved,	it	is	currently	unknown	how	the	
strand	 discrimination	 in	 eukaryotes	 takes	 place	 [85].	 In	 addition,	 there	 are	 some	 other	
differences	 regarding	 the	 protein	 functions	 between	 bacteria	 and	 eukaryotes.	 MutS	 and	
MutL	 proteins,	 the	 core	 MMR	 factors,	 are	 present	 as	 homodimers	 in	 E.coli	 while	 in	
eukaryotic	 cells	 several	 heterodimeric	 complexes	 are	 formed	 by	 their	 homologues	 [85].	
MutSα,	 composed	 of	 MSH2	 and	 MSH6,	 binds	 to	 base-base	 mismatches	 and	 to	 small	
insertion-deletion	 loops	 (IDLs)	 of	 1-2	 nucleotides	 [86].	 On	 the	 other	 hand,	 MutSβ,	 a	
heterodimer	of	MSH2	and	MSH3,	recognises	IDLs	of	1-14nt	[87,	88].	Evidence	suggests	that	
MutSα	 as	well	 as	MutSβ	 are	 able	 to	 initiate	 repair	 of	 small	 IDLs	 [86].	 In	 addition	 to	 their	
mismatch-binding	domains,	both	protein	complexes	also	display	ATPase	activity	mediated	by	
Walker-type	 ATPase	 domains	 that	 are	 present	 in	 both	 subunits	 of	 MutSα	 and	 MutSβ,	
respectively	 [89].	 Among	 the	 other	 key	 players	 in	 the	MMR	 reactions	 in	 eukaryotic	 cells,	
there	 are	 three	 heterodimers:	 MutLα	 (MLH1/PMS2),	 MutLβ	 (MLH1/PMS1)	 and	 MutLγ	
(MLH1/MLH3)	[90].	Briefly,	the	model	for	eukaryotic	MMR,	especially	in	mammals,	involves	
the	 recognition	of	 a	mismatch	 in	 the	DNA	by	MutSα	or	MutSβ	 (Figure	4).	After	mismatch	
binding,	MutSα	 (MutSβ)	 is	 converted	 into	 a	 DNA	 sliding	 clamp	 that	 comes	 along	with	 an	
exchange	 of	 ADP	 to	 ATP	 in	 the	 ATP-binding	 pocket	 of	 the	 complex	 [91,	 92].	 Next,	MutLα	
associates	 with	 the	 sliding	 clamp	 and	 mediates	 endonucleolytic	 incision	 of	 the	 error-
containing	DNA	strand	[93].	Complete	removal	of	the	damaged	strand	is	then	carried	out	by	
Exonuclease	1	(EXO1)	[84].	Finally,	the	resulting	single-stranded	(ss)	DNA	gap	is	then	filled-in	
by	a	DNA	polymerase	such	as	Pol	δ	and	sealed	by	 ligase	 I	 [83].	 It	has	been	shown	in	yeast	
that	the	 incision	 in	case	of	a	mismatch	 in	the	 leading	strand	can	be	mediated	by	RNaseH2	
cleavage	 of	 mis-incorporated	 ribonucleotides,	 providing	 an	 entry	 side	 for	 EXO1-mediated	





E.coli,	 the	 excision	 step	 is	 assisted	 by	 the	 UvrD	 helicase	 that	 unwinds	 the	 DNA	 until	 the	
mismatch	 is	 reached,	 the	 resulting	 ssDNA	 is	 then	 cleaved	 by	 an	 exonuclease	 (RecJ	 or	
Exo1)[94].	In	human	cells	the	identity	of	the	helicase	that	mediates	this	step	is	unknown,	but	












a	 single	base,	 the	base	excision	 repair	 (BER)	pathway	 is	 activated	 to	 replace	 the	damaged	
base	with	an	intact	one	(Figure	5)	[44,	97-100].	About	104	bases	in	every	cell	per	day	are	hit	
solely	 by	 spontaneous	 depurination	making	 BER	 important	 to	maintain	 genomic	 integrity,	
which	 is	underlined	by	 the	 fact	 that	 this	 repair	 system	 is	highly	conserved	between	E.	 coli	
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and	 mammals	 [101,	 102].	 Todays	 mechanistic	 model	 of	 BER	 divides	 it	 into	 two	 distinct	
pathways,	 the	 short	 and	 the	 long-patch	 BER	 [103]	 (Figure	 5).	 The	 first	 one	 results	 in	 the	
repair	 of	 a	 single	 nucleotide	 while	 the	 latter	 exchanges	 at	 least	 two	 nucleotides	 [97].	 To	
initiate	short-patch	BER,	a	specific	DNA	glycosylase	recognises	a	damaged	base	and	removes	
it	 by	 cleaving	 the	 N-glycosidic	 bond	 leaving	 behind	 an	 apurinic	 or	 apyrimidinic	 site	 (AP	
site)[97,	104].	Subsequently,	an	AP	endonuclease	1(APE1)	cuts	the	DNA	backbone	5’	of	the	
AP	 site	 [105].	 Then	 the	 polymerase	 β	 fills	 in	 the	 corresponding	 nucleotide	 [106,	 107].	
Ultimately,	 the	 sealing	of	 the	 remaining	nick	 is	 carried	out	by	DNA	Ligase	 III/XRCC1.	 Long-





of	 the	 lesion	 is	 mediated	 by	 enzymes	 of	 the	 Poly(ADP-ribose)	 polymerase	 (PARP)	 family,	
primarily	PARP1	[110,	111].	
	




different	 factors	 are	 recruited	 after	 APE1	 cleavage	 to	 complete	 DNA	 repair.	 Trough	 its	 strand	 displacement	
activity	 Pol	 δ	 or	 ε	 resynthesizes	 the	 DNA	 producing	 a	 5’	 flap	 that	 is	 cleaved	 by	 FEN1/PCNA	 and	 genomic	





The	 presence	 of	 a	 DNA	 DSB	 in	 genomic	 DNA	 is	 a	 very	 dangerous	 situation	 for	 a	 cell.	
Therefore	different	mechanisms	have	evolved	in	eukaryotic	cells	to	antagonize	these	lesions.	
Non-homologous	end-joining	(NHEJ),	being	one	of	these	mechanisms,	can	rapidly	repair	DNA	





being	 further	 processed.	 The	 protein	 forms	 a	 ring-shaped	 structure	 that	 can	 encircle	 the	








Such	 end-blocking	 obstacles	 are	 for	 instance	 chemical	 adducts	 or	 the	 absence	 of	 5’	
phosphate	 or	 3’	 hydroxyl	 groups	 at	 the	 DNA	 termini.	 Therefore,	 various	 proteins	may	 be	
required	 to	make	 the	ends	permissive	 for	 repair.	Not	only	nucleases	 like	Artemis,	WRN	or	
APLF,	 but	 also	 polymerases	 have	 been	 shown	 to	 act	 during	 this	 step	 of	 NHEJ	 [121,	 122].	
Finally,	 the	 DNA	 Ligase	 IV/XRCC4/XLF	 complex	 seals	 together	 the	 DNA	 ends	 to	 restore	
genomic	integrity.	In	this	reaction,	XRCC4	might	also	serve	as	a	scaffold	for	the	recruitment	
of	additional	NHEJ	proteins,	however	 it	also	stimulates	 the	Ligase	 IV	activity	 [115,	123].	 In	










complex	 to	DNA	ends	of	a	DNA	DSB	 is	 followed	by	 recruitment	of	 the	DNA-dependent	protein	kinase	 to	 the	
damage	site.	The	next	step	includes	processing	of	the	DNA	ends	to	make	them	compatible	for	further	repair.	
Several	nucleases	and	DNA	polymerases	have	been	 shown	 to	act	at	 this	 step.	The	DNA	Ligase	 IV/XRCC4/XLF	
complex	then	mediates	religation	of	the	broken	DNA	end.	Abbreviations:	DNA	DSB,	DNA	double-strand	break.	
Adapted	and	modified	from	[127].		
There	 is	 another,	 but	 less	 well	 characterized,	 NHEJ	 pathway	 present	 in	 cells	 that	 is	 Ku-
independent.	 This	 pathway	 is	 termed	 alternative	 end-joining	 or	microhomology-mediated	












are	 purposely	 generated	 by	 Spo11	 [61,	 126].	 HR	 is	 therefore	 involved	 in	 the	 crossover	
formation	during	meiosis	I	that	is	important	for	alignment	of	the	homologous	chromosomes	
and	 their	 subsequent	 segregation	 [129].	 In	 addition,	 this	 repair	 pathway	 is	 responsible	 to	
generate	genetic	diversity	[130].	Furthermore,	HR	also	plays	roles	in	recovery	of	stalled	and	






there	are	 fewer	 factors	 involved	 in	yeast	HR	as	compared	to	HR	 in	higher	eukaryotes,	and	
the	 model	 has	 been	 updated	 during	 the	 past,	 the	 principle	 remains	 the	 same.	
Mechanistically,	HR	 can	 be	 divided	 into	 several	 steps:	 (i)	 nucleolytic	 resection	 of	 the	DNA	
DSB	 ends;	 (ii)	 formation	 of	 a	 nucleoprotein	 filament;	 (iii)	 homology	 search	 and	 strand	
invasion;	 (iv)	 DNA	 repair	 synthesis;	 and	 (v)	 resolution	 of	 recombination	 intermediates	 via	
different	sub-pathways	(Figure	7)	[131,	132].	
	 After	 initiation	 of	 HR	 by	 DNA	 damage	 like	 a	 DNA	 DSB,	 the	 DNA	 ends	 are	 first	
processed	 to	 generate	 3’	 ssDNA	 overhangs.	 From	 studies	 in	 yeast	 it	 is	 known	 that	 four	
nucleases	 participate	 in	 this	 first	 step:	 the	 Mre11-Rad50-Xrs2	 (MRX)	 complex	 [Mre11-
RAD50-NBS1	 (MRN)	 in	 humans],	 Exonuclease	 1	 (Exo1)	 (EXO1	 in	 humans),	 DNA	 replication	
helicase/nuclease	 2	 (Dna2)	 (DNA2	 in	 humans)	 and	 Sae2	 (CtIP	 in	 humans)	 (Figure	 7).	 The	
ssDNA	 generated	 in	 the	 DNA-end	 resection	 process	 is	 covered	 by	 the	 ssDNA-binding	
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to	 be	 removed	 prior	 to	 Rad51	 loading.	 Therefore,	 mediator	 proteins,	 divided	 into	 three	
different	 sub-classes,	 are	 assisting	 in	 this	 process	 to	 overcome	 this	 obstacle	 and	 assist	 in	
further	 downstream	 steps	 [130,	 136].	 The	 first	 class	 of	 these	 effectors	 in	 S.cerevisiae	
comprises	of	the	Rad51	paralogs	known	as	the	Rad55-Rad57	complex	and	heterodimers	of	
the	Shu	proteins	 (Shu1,	Shu2,	Psy3,	and	Csm2)	[130,	137].	 In	mammalian	cells,	 five	RAD51	
paralogues	 were	 identified	 so	 far,	 which	 form	 two	 distinct	 protein	 complexes	 (RAD51B-
RAD51C-RAD51D-XRCC2	 and	 RAD51C-XRCC3).	 Studies	 in	 yeast	 have	 shown	 that	 these	
proteins	 might	 be	 involved	 in	 the	 stabilisation	 of	 the	 nucleoprotein	 filament	 [138].	
Moreover,	 studies	 done	 in	C.	elegans	provided	 evidence	 that	 the	 Rad51	 paralogs	 actively	
contribute	to	Rad51	filament	remodelling,	thereby	promoting	strand	exchange	and	HR	[139].	





appropriate	 DNA	 template	 like	 the	 sister	 chromatid.	 Subsequent	 strand	 invasion	 is	 then	
completed	with	the	formation	of	a	displacement	loop	(D-loop)	(Figure	7).	Afterwards	distinct	
polymerases	 use	 the	 invading	 strand	 as	 a	 primer	 to	 start	 DNA	 synthesis.	 In	 humans	 it	 is	
known	that	also	translesion	polymerases	can	mediate	this	DNA	extension	step	in	addition	to	
the	replicative	polymerase	δ.	A	key	player	within	this	process	is	the	Rad54	motor	protein.	It	
stabilises	 the	 Rad51	 nucleoprotein	 filament	 and	 promotes	 D-loop	 formation.	 Eventually,	
Rad54	disrupts	the	Rad51	filament	to	allow	initiation	of	DNA	synthesis	[130,	131,	141,	142].	
	 To	complete	HR,	one	out	of	three	possible	sub-pathways	can	be	followed	(Figure	7).	
These	 are	 called:	 (i)	 break-induced	 replication	 (BIR);	 (ii)	 synthesis-dependent	 strand	
annealing	(SDSA);	and	(iii)	the	classical	DNA	DSB	repair	(DSBR).	The	latter	pathway	involves	
the	 formation	of	 a	 double	Holliday	 junction	 structure	 (dHJ)	 [130].	 BIR	 takes	 place	when	 a	
DNA	 DSB	 has	 only	 one	 accessible	 end	 as	 in	 the	 case	 of	 collapsed	 replication	 forks	 or	
unprotected	 telomeres	 [143].	 This	 repair	 pathway	 converts	 the	 D-loop	 into	 a	 replication	
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fork-like	 structure	 and	 DNA	 synthesis	 is	 then	 carried	 out	 until	 the	 chromosome	 end	 is	
reached,	 leading	to	a	restoration	of	the	genomic	 integrity.	However,	 loss-of-heterozygosity	
(LOH)	 and	 genomic	 duplications	 are	 potential	 outcomes	 of	 this	 reaction	 [143,	 144].	 If	 a	
second	 DNA	 end	 is	 present,	 somatic	 cells	majorly	 follow	 the	 SDSA	 pathway	 [145].	 In	 this	




proteins	 involved	 in	 its	 processing,	 the	 result	 is	 either	 a	 non-crossover	 or	 a	 crossover	
outcome.	For	the	 latter,	 it	has	been	shown	that	 in	human	cells	the	SLX1-SLX4	and	MUS81-
EME1	 protein	 complexes	 and	 the	 Gen1	 resolvase	 are	 involved	 that	 all	 display	 distinct	
endonuclease	 activities	 [147-149].	 On	 the	 other	 hand,	 the	 Sgs1	 (BLM	 in	 humans)-DNA	















Figure	 7:	 Repair	 of	 DNA	 double-strand	 break	 by	 homologous	 recombination.	 The	 first	 step	 of	 HR	 is	 called	
DNA-end	 resection	 and	 leads	 to	 the	 generation	 of	 3’	 ssDNA	 overhangs	 that	 are	 then	 coated	 by	 RPA.	 Four	
nucleases	 are	 known	 to	 be	 involved	 in	 this	 process:	 the	Mre11-Rad50-Xrs2	 complex,	 Exo1,	 Dna2	 and	 Sae2.	
Mediator	 proteins	 like	 the	 Rad51	 paralogs	 or	 BRCA2	 then	 load	 the	 Rad51	 recombinase	 on	 the	 RPA-coated	




DNA	DSB	 repair	 that	proceeds	 via	double	Holliday	 junction	 formation.	 Every	 sub-pathway	 leads	 to	a	 specific	
repair	product	with	crossover	or	non-crossover	outcome.	The	presence	of	 repeats	adjacent	 to	 the	break	site	
allows	 repair	 trough	 single-strand	 annealing	 pathway	 after	 extensive	 DNA-end	 resection.	 Proteins	 from	
S.cerevisiae	 and	 humans	 are	 written	 in	 blue	 and	 brown	 colour,	 respectively.	 Broken	 lines	 refer	 to	 newly	
synthesised	 DNA.	 Abbreviations:	 SSA,	 single-strand	 annealing;	 SDSA,	 synthesis-dependent	 strand	 annealing;	




Processing	 of	 DNA	 ends	 after	 DSB	 formation	 is	 essential	 for	 HR	 to	 proceed.	 The	 5’	








ends	 are	 first	 processed	 by	MRX	 in	 complex	with	 Sae2	 to	 generate	 a	 short	 ssDNA	 tail	 of	
about	 50-100nt	 [134].	 Next,	 one	 of	 the	 two	 above-mentioned	 pathways	 can	 take	 over	 to	




5’	 terminated	 strand	downstream	of	 the	DNA	end,	 creating	 an	 entry	 site	 for	 Exo1	 and/or	
Dna2/Sgs1	[157].	
Several	 studies	 have	 shown	 that	 also	 RPA	 is	 crucial	 for	 DNA-end	 resection	 since	 it	
stimulates	 the	 unwinding	 activity	 of	 Sgs1	 [158].	 Further,	 RPA	 directs	 Dna2-mediated	
degradation	of	DNA	towards	the	5’	terminated	strand	and	protects	the	3’	strand	since	Dna2	
is	 only	 able	 to	 displace	 RPA	 from	 the	 5’	 strand	 [158-160].	 In	 addition,	 the	 Top3-Rmi1	
complex	 that	 is	 involved	 in	dHJ	dissolution	has	been	 shown	 to	have	 stimulatory	 effect	 on	
Sgs1/Dna2-mediated	 resection	 by	 enhancing	 the	 unwinding	 activity	 of	 Sgs1	 [158].	 Taken	
together,	 these	data	 suggest	 that	MRX/Sae2	display	a	 first,	 limited	end-processing	activity	








xDNA2	 to	 promote	 extensive	 DNA-end	 resection	 [162,	 163].	 Related	 to	 yeast	 RPA,	 xRPA	
interacts	with	xWRN	directly	and	stimulates	its	helicase	activity	thereby	enhancing	the	DNA	
end	processing	reaction	mediated	by	xDNA2/xWRN	[164].	Although	the	MRN	complex	was	
able	to	stimulate	both	 long-range	resection	pathways,	which	 is	 in	 line	with	the	yeast	data,	





















activities	 have	 to	 be	 coordinated	 both	 spatially	 and	 temporally.	 Deregulated	 enzymatic	
activity	within	repair	processes	can	have	devastating	outcome	not	only	to	the	cell	itself	but	
also	to	the	whole	organism	in	case	of	cell	transformation	into	a	cancer	cell.	In	the	following	





as	DNA-PK,	belong	to	the	phosphatidylinositol	3-kinase	 like	protein	kinase	 (PIKK)	 family.	 In	
addition,	the	PARP	proteins,	of	which	17	are	known	in	humans,	are	also	crucial	for	the	DDR	
[169-171].	 Upon	 DNA	 DSB	 formation,	 PARP1	 and	 PARP2	 get	 activated	 and	 start	 the	
formation	of	poly(ADP-ribose)	(PAR)	chains	on	target	proteins.	These	PAR	chains	serve	as	a	
scaffold	to	recruit	other	factors	to	the	DNA-damage	site	[172].	One	of	these	proteins	is	the	
MRN	complex,	which	 is	known	to	 interact	with	PAR	molecules	via	 its	Mre11	subunit	[171].	





marker	 of	 DNA	 damage	 [171,	 175].	 MDC1	 then	 binds	 γH2AX	 and	 mediates	 further	
recruitment	 of	 ATM	 resulting	 in	 an	 amplification	 of	 the	 γH2AX	 signal	 that	 can	 spread	
approximately	1-2	megabases	from	the	DNA	DSB	site	[171].	Activated	MDC1	then	mediates	
an	 exchange	 from	 a	 phosphorylation	 to	 an	 ubiquitination	 signal	 cascade	 by	 recruiting	 the	
ubiquitin	ligases	RNF8	and	RNF168	[176].	Linking	ubiquitin	moieties	to	target	proteins	leads	
to	 the	 recruitment	of	RAP80	that	 interacts	with	BRCA1	 [171].	Although	the	BRCA1	protein	
has	been	shown	to	be	involved	in	promoting	HR	the	underlying	mechanisms	remain	elusive.	
It	has	been	demonstrated,	that	BRCA1	can	associate	with	CtIP	in	S	and	G2	phases	of	the	cell	
cycle	where	 it	may	play	 a	 role	 in	 activation	 of	 extensive	 resection	 that	 is	 required	 for	HR	
[177].	However,	HR	can	only	repair	DNA	DSBs	if	a	template	sequence	is	present.	It	has	been	
shown	 that	 53BP1,	 which	 also	 gets	 recruited	 to	 these	 damage	 sites	 by	 the	 described	
signalling	cascade,	 inhibits	resection	and	promotes	NHEJ	under	certain	circumstances	[178,	
179].		











complex	 and	 the	 ATM	 kinase.	 ATM	 phosphorylates	 the	 histone	 variant	 H2AX	 that	 is	 important	 for	 MDC1	
recruitment.	 In	 addition,	 it	 also	 activates	 the	 checkpoint	 kinase	 CHK2,	 leading	 to	 a	 cell	 cycle	 stop	 to	 allow	
restoration	of	 the	DNA	 integrity	or	apoptosis	 trough	p53.	MDC1	then	 recruits	 the	key	ubiquitin	 ligases	RNF8	








dsDNA	 at	 the	 ssDNA/dsDNA	 junction	 by	 the	 RAD17-RFC	 clamp	 loader	 [184,	 185].	 TOPBP1	





in	 a	 manner	 dependent	 on	 the	 MRN	 complex	 without	 the	 use	 of	 the	 9-1-1	 complex.	
Especially	the	interaction	between	NBS1	and	RPA	seems	to	be	crucial	for	this	MRN-mediated	
ATR	 activation	 [190].	 This	 suggests	 that	 there	 are	 several	 pathways	 involved	 in	 ATR	
activation	once	RPA-coated	ssDNA	has	been	formed.		
	 DNA	damage	recognition	and	signalling	 is	a	very	 important	process	 for	cells	and,	 in	
general,	specialised	proteins	carry	out	this	process.	Interestingly,	it	has	been	demonstrated	
that	some	factors	of	the	MMR	system	might	also	be	involved	in	DNA	DSB	repair	[191-194].	
MSH2	has	been	shown	to	be	 important	 for	efficient	HR-mediated	 repair	of	DNA	DSBs	and	
checkpoint	activation	[195-197].	In	addition,	a	recent	study	has	shown	that	MutSβ	seems	to	
be	important	for	DNA	DSB	repair,	since	cells	defective	for	either	subunit	of	this	MMR	protein	
display	 elevated	 levels	 of	 chromatid	 breaks	 [198].	 However,	 the	 exact	 role	 of	 MutSβ	 in	








by	ATRIP	 that	 directly	 interacts	with	RPA.	 In	 parallel,	 the	 RAD9-RAD1-HUS1	 complex	 recruits	 TOPBP1	 to	 the	




not	all	of	 them	might	be	suitable	at	a	given	scenario.	Therefore,	 the	selection	of	 the	most	










repair	 pathways	 have	 their	 own	 consequences	 to	 the	 genomic	 integrity.	 The	 deleterious	
MMEJ	and	SSA	mechanisms	and	BIR,	possibly	resulting	in	LOH,	have	mutagenic	potential	and	
are	therefore	likely	to	be	suppressed	if	other	systems	can	be	applied.	Therefore,	in	yeast	and	
mammalian	 cells,	 it	 has	 been	 shown	 that	 HR	 mainly	 proceeds	 trough	 SDSA	 pathway	 in	
mitotic	cells,	since	the	formation	of	dHJs	may	end	up	in	chromosomal	rearrangements	giving	
rise	 to	 genomic	 instability	 [203,	 204].	 In	 vitro	 studies	 demonstrated,	 that	 Rad51	 actively	
inhibits	 the	 formation	 of	 dHJs	 and	 therefore	 favours	 repair	 trough	 SDSA,	 but	 the	
mechanisms	underlying	the	regulation	of	HR	pathway	choice	are	still	not	very	well	defined	
[130,	 205].	 From	 studies	 in	 yeast,	 it	 is	 known	 that	 Mph1,	 a	 DNA	 helicase,	 counteracts	
formation	of	crossovers	[206].	Further,	another	helicase	called	Srs2	is	also	able	to	suppress	
crossover	products	[207].	In	mammalian	cells,	FBH1	displays	the	highest	sequence	homology	
to	 Srs2,	however	 its	 role	 in	 SDSA	 remains	elusive	 [208].	Other	 studies	have	demonstrated	










conjunction	 with	 DNA2	 can	 mediate	 5'-3'-directed	 DNA-end	 resection	 in	 a	 reaction	
dependent	on	RPA	and	ATP.	In	addition,	we	found	that	WRN	and	DNA2	interact	physically	in	
vitro	and	in	vivo	and	mapped	the	interaction	site	of	DNA2	on	WRN	by	using	GST-tagged	WRN	
fragments.	We	 then	 sought	 to	 define	 the	 roles	 of	 these	 proteins	 in	DNA-end	 resection	 in	
vivo.	Through	a	chromosomally-based	 reporter	assay	 for	DNA	DSB	repair	by	SSA,	we	were	
able	 to	 show	 that	 WRN	 and	 BLM	 act	 epistatically	 with	 DNA2	 to	 promote	 long-range	
resection	 of	 endonuclease-induced	DNA	DSBs	 in	 human	 cells.	 In	 addition,	we	 obtained	 in	
vitro	and	in	vivo	data	suggesting	that	BLM	promotes	DNA-end	resection	as	part	of	the	BLM-
TOPOIIIα-RMI1-RMI2	complex.	Taken	together	we	propose	a	model,	where	 in	DNA2/WRN,	
DNA2/BLM-TRR	 and	 EXO1	 constitute	 the	 resection	 machineries	 responsible	 for	 extensive	
DNA-end	resection	(Sturzenegger	et	al.,	JBC;	see	2.2.1.).	
	 Next,	we	identified	the	mismatch-binding	protein	MutSβ,	a	heterodimer	of	MSH2	and	
MSH3,	 as	 a	mediator	 in	 the	 process	 of	 ATR	 activation.	We	 showed	 that	MSH2	 and	MSH3	
form	a	complex	with	ATR	and	its	regulatory	partner	ATRIP,	and	their	depletion	compromises	
the	 formation	 of	 ATRIP	 foci	 and	 phosphorylation	 of	 ATR	 substrates	 in	 cells	 responding	 to	
replication-associated	 DNA	 DSBs.	 By	 using	 purified	MutSβ,	 we	 were	 able	 to	 show	 that	 it	
binds	 to	 hairpin	 loop	 structures	 persisting	 in	 RPA-ssDNA	 complexes	 and	 promotes	 ATRIP	
recruitment.	 Mutating	 the	 mismatch-binding	 domain	 of	 MSH3	 abolished	 the	 binding	 of	
MutSβ	 to	 DNA	 hairpin	 loops	 and	 its	 ability	 to	 promote	 ATR	 activation	 by	 ssDNA.	
Interestingly,	 in	 the	 presence	 of	 ATP/Mg2+,	 MutSβ	 dissociated	 from	 ssDNA	 and	 the	 ATR-
ATRIP	complex.	These	results	suggest	that	hairpin	loops	form	in	ssDNA	generated	at	sites	of	











this	 observation,	 we	 showed	 that	 knockdown	 of	 RECQ5	 resulted	 in	 a	 decrease	 in	 SSA	
efficiency.	These	results	indicate	that	RECQ5	enhances	SSA	repair	by	removing	RAD51	from	
ssDNA.	 Using	 purified	 recombinant	 human	 proteins	 in	 an	 in	 vitro	 RAD52-mediated	 DNA	
annealing	 assay,	 we	 were	 able	 to	 gain	 insight	 into	 the	 molecular	 mechanism	 of	 RAD51-
ssDNA	 filament	 dynamics	 and	 could	 further	 strengthen	 our	 in	 vivo	 data.	 Next,	 we	 used	
chromatin	immunoprecipitation	(ChIP)	to	show	that	abundance	of	RAD51	near	a	given	DNA	
DSB	 site	 is	 augmented	 in	 RECQ5-deficient	 cells,	 indicating	 involvement	 of	 RECQ5	 in	
regulation	of	RAD51	 filament	 formation	at	DNA	DSBs.	 Furthermore,	we	 found	 that	RECQ5	
depletion	 in	cells	 lacking	BLM	 leads	 to	 increased	 frequency	of	 sister	 chromatid	exchanges,	
further	supporting	our	model	that	RECQ5	is	involved	in	promoting	SDSA	(Paliwal	et	al.,	NAR;	
See	2.2.3.).	
	 In	 collaboration	with	 the	 laboratory	of	Prof.	 Eli	Rothenberg,	we	could	demonstrate	
how	 BLM	 interacts	 with	 intra-strand	 G4	 structures.	 By	 applying	 single-molecule	 FRET	
technique,	we	were	able	to	show	that	the	activity	of	BLM	is	substrate	dependent,	and	highly	


















In	 this	 work,	 I	 purified	 recombinant	 human	 wild-type	 WRN,	 helicase-	 and	 nuclease-dead	
WRN	mutants,	 DNA2	 and	 BLM	 from	 Sf-9	 insect	 cells	 as	 well	 as	 RPA	 from	 E.	 coli.	 Next,	 I	
carried	 out	 all	 in	 vitro	 DNA-end	 resection	 and	 helicase	 assays.	 To	 demonstrate	 the	
interaction	between	WRN	and	DNA2,	 I	 performed	binding	 assays	with	 full-length	proteins	
























































Here,	 I	 first	 constructed	 different	 plasmids	 for	 expression	 of	 MSH3	 in	 human	 cells	
(pcDNA3.1-	 and	 pEGFP-c1-vector)	 and	 for	 generation	 of	 bacmids	 (pFastBac1-vector).	 In	
addition,	I	also	generated	various	MSH3	mutant	constructs,	where	the	loop-binding	motif	of	
MSH3	 has	 been	 mutated	 (MSH3-Y245S,	 MSH3-K246E	 and	 MSH3-Y245S/K246E).	 Next,	 I	


































































































For	 this	 study	 I	 performed	 a	 number	 of	 SA-GFP	 and	 DR-GFP	 reporter	 experiments.	 To	
optimize	 the	 production	 and	 purification	 of	 RAD51	 wt	 and	 its	 K133R	 mutant	 version,	 I	
constructed	new	expression	vectors	based	on	the	pTXB3	plasmid	from	New	England	Biolabs	
and	 subsequently	 purified	 both	 proteins.	 Further,	 I	 conducted	 strand-annealing	 assays	 to	
show	that	wild-type	RAD51	also	displayed	a	similar	effect	like	the	RAD51-K133R	mutant	and	





































































































































one	 of	 the	 first	 proteins	 present	 at	 the	 break	 site	 and	 plays	 a	 crucial	 role	 in	 resection	
initiation	 [217].	 This	 might	 imply	 that	 MRN	 recruits	 WRN	 to	 sites	 of	 DNA	 DSBs	 to	 start	
extensive	resection.		
Our	 finding	 that	 the	 exonuclease	 domain	 of	WRN	 is	 dispensable	 for	 its	 function	 in	
DNA-end	 resection	 in	 conjunction	with	DNA2	 is	 consistent	with	 the	observation	 that	MRN	
stimulates	WRN’s	helicase	but	not	exonuclease	activity	 [217].	The	exonuclease	 function	of	
WRN	seems	 to	be	 rather	 involved	 in	other	processes	 like	 the	protection	of	 reversed	 forks	
upon	replication	stress	or	the	DNA-end	processing	during	NHEJ	 [218,	219].	Taken	together	
these	data	demonstrate	that	WRN	is	a	crucial	factor	in	the	repair	of	DNA	DSBs	and	that	the	
two	 functional	domains	of	 this	protein	mediate	distinct	 functions	 in	 this	 complex	process.	
	 Further	prove	that	WRN	is	a	key	player	in	preserving	genome	stability	is	provided	by	
phenotypes	of	patients	 suffering	 from	WS.	 This	disorder	 caused	by	 inherited	mutations	 in	
the	WRN	gene	is	characterized	by	premature	aging	and	cancer	predisposition	[220].	On	the	
cellular	 level,	 lack	 of	 WRN	 is	 manifested	 in	 extensive	 chromosomal	 deletions	 and	
translocations	[221-223].	However	it	should	be	noted	that	these	symptoms	are	likely	caused	
not	only	by	a	DNA-end	resection	defect	but	also	by	failure	of	several	other	processes	where	
WRN	 is	 involved.	 For	 instance,	 it	 has	 been	 shown	 that	 WRN	 participates	 in	 telomere	







In	 this	study	we	found	that	 like	yeast	Dna2,	also	the	human	ortholog	relies	on	 free	
ssDNA	 ends	 to	mediate	 an	 endo/exonucleolytic	 flap	 cleavage	 [152,	 226].	 In	 line	with	 this	
observation	recent	work	in	Xenopus	egg	extracts	revealed	that	DNA	DSB	break	ends	with	5’	













where	 TRR	 stimulated	 the	 DNA	 end	 processing	 activity	 of	 BLM/DNA2	 only	 to	 a	 limited	
extent,	 depletion	 of	 RMI1	 from	 U2OS	 cells	 lead	 to	 a	 marked	 reduction	 in	 SSA	 repair	
efficiency.	 These	 data	 indicate	 that	 in	 vivo,	 RMI1	 is	 crucial	 for	 the	 DNA-end	 resection	
reaction	promoted	by	BLM/DNA2.	Consistent	with	this	observation,	it	has	been	shown	that	




events	 that	 are	 dependent	 on	 extensive	 resection,	 whereas	 in	 U2OS	 cells	 a	 marked	
reduction	 was	 noticed.	 In	 addition,	 we	 found	 that	 the	 concentration	 of	 BLM	 protein	 in	
HEK293	cells	was	much	higher	than	 in	U2OS	cells	 (data	not	shown).	 	Therefore,	 in	HEK293	
cells	where	BLM	exceeds	a	certain	threshold,	it	might	counteract	the	repair	of	DNA	DSB	via	







only	 in	processing	DNA	ends	after	DNA	DSBs,	but	also	 in	 resection	of	 reversed	 replication	
forks	to	allow	a	proper	replication	restart.	Interestingly,	BLM	seems	to	play	only	a	minor	role	
in	 this	mechanism	 demonstrating	 that	 the	 different	 resection	machineries	may	 also	 have	
distinct	functions	in	human	cells	[233].		
In	 addition	 to	 the	 investigation	 on	 how	RPA-coated	 ssDNA	 is	 generated	 at	 sites	 of	
DNA	DSBs,	we	also	asked	how	this	nucleoprotein	structure	activates	simultaneously	the	ATR	
signalling	 cascade.	 We	 identified	 the	 mismatch-binding	 protein	 MutSβ,	 a	 heterodimer	 of	
MSH2	 and	MSH3,	 as	 a	mediator	 of	 ATR	 activation.	We	 have	 found	 that	MSH2	 and	MSH3	
associate	with	 the	 ATR-ATRIP	 complex	 and	 are	 required	 for	 ATRIP	 foci	 formation	 and	 the	
phosphorylation	 of	 ATR	 targets	 in	 U2OS	 cells	 treated	with	 CPT,	 which	 induces	 DNA	 DSBs	
during	DNA	 replication.	Further,	we	have	obtained	evidence	 for	 the	persistence	of	hairpin	
loops	 in	RPA-coated	 ssDNA	 in	 vitro,	which	are	 recognised	by	MutSβ.	 To	demonstrate	 that	
MutSβ	specifically	associates	with	persisting	hairpin	 loop	structures	 in	ssDNA,	we	mutated	
the	 amino	 acids	 in	 MSH3	 that	 are	 responsible	 for	 mismatch	 binding.	We	 found	 that	 the	
interaction	of	MutSβ	mutant	with	hairpin	loops	was	completely	abrogated	in	vitro.	Further,	
we	 demonstrated	 that	 this	 MutSβ	 mutant	 failed	 to	 stimulate	 ATR	 activation	 in	 nuclear	
extracts	 supplemented	 with	 ssDNA	 and	 in	 human	 cells	 treated	 with	 CPT.	 These	 results	
demonstrate	that	binding	of	MutSβ	to	hairpin	loop	structures	persisting	in	ssDNA	is	essential	
to	 mediate	 ATR	 activation.	 Finally,	 we	 found	 that	 MutSβ	 dissociates	 from	 ssDNA	 hairpin	
loops	upon	addition	of	ATP	and	Mg2+.	
It	has	been	shown	previously	that	embryonic	fibroblasts	from	MSH2	knockout	mice	
displayed	a	 reduced	 survival	 rate	upon	DNA	damage	 induction	by	X-rays	 that	 induce	DNA	
DSBs	[196].	In	addition,	in	these	cells	the	checkpoint	kinase	CHK1	was	only	active	for	limited	
time	 and	 CHK2	 was	 not	 phosphorylated	 leading	 to	 improper	 G2/M	 checkpoint	 function	
[196].	Although	 it	has	been	demonstrated	 that	also	MutSα	 in	conjunction	with	MutLα	can	
activate	 ATR,	 this	 mechanism	 occurs	 in	 a	 resection	 independent	 manner	 [234,	 235].	
Consistent	with	these	results,	we	also	observed	an	impaired	phosphorylation	of	ATR	targets	





In	 our	 proposed	 model,	 MutSβ	 binds	 to	 hairpin	 loops	 bringing	 the	 ATR-ATRIP	
complex	in	close	proximity	to	the	RPA-coated	ssDNA	formed	after	DNA	end	processing.	This	
would	allow	 subsequent	ATR	activation	by	TOPBP1	 that	 gets	 loaded	on	 the	 ssDNA/dsDNA	
junction	by	the	9-1-1	complex	[183,	186].	Interestingly,	work	done	in	yeast	showed	that	the	
9-1-1	checkpoint	clamp	is	able	to	promote	DNA-end	resection	by	Dna2	and	Exo1	[236].	If	this	
also	 holds	 true	 for	 mammalian	 cells,	 it	 suggests	 that	 DNA	 end	 processing	 is	 possibly	
enhanced	under	certain	circumstances	to	generate	the	substrate	for	MutSβ	binding	and	thus	
increased	ATR	activation.	
It	 has	 been	 published	 previously	 that	 ATR	 is	 important	 to	 prevent	 uncontrolled	
replication	origin	firing	and	protects	replication	forks	following	replication	stress	[237].	This	
mechanism	is	important	to	overcome	the	generation	of	loads	of	ssDNA	that	would	exhaust	
the	 cellular	 RPA	 pool	 [237].	 It	 is	 therefore	 possible	 that	 persisting	 hairpin	 loops	 in	 RPA-
coated	 ssDNA	 reflect	 a	 low	 amount	 of	 free	 RPA	 and	 thus	 lead	 to	MutSβ	 association	 and	
subsequent	enhanced	ATR	activation.	However	in	our	DNase	I	footpriting	assays,	we	found	
that	even	 in	 the	presence	of	 an	2-fold	excess	of	RPA	over	RPA	binding	 sites	 in	 the	 ssDNA	
substrate,	 hairpin	 structures	 were	 still	 present.	 This	 suggests	 that	 hairpin	 loops	 are	
potentially	also	 formed	within	RPA-coated	 ssDNA	under	normal	 conditions	 to	 form	MutSβ	
binding	sites.		
In	 our	 experiments,	 we	 found	 that	 MutSβ	 disassociates	 from	 hairpin	 loops	 upon	
addition	 of	 ATP.	 This	 is	 probably	 required	 to	 remove	 the	 protein	 from	 the	 DNA	 so	 that	
homology-directed	repair	can	proceed.	A	multi	step	process,	including	ATP	binding	by	MSH3,	

















at	 sites	 adjacent	 to	DNA	DSBs	 is	 increased	 as	 compared	 to	 normal	 cells.	 Finally,	we	 show	
RECQ5	and	BLM	act	 is	 a	 complementary	 fashion	 to	 suppress	 sister	 chromatid	exchange	 in	




of	 SCEs	 [212].	 In	 addition,	mice	 lacking	 RECQ5	 are	 prone	 to	 develop	 cancer	 [209].	 These	
malignancies	probably	arise	because	of	the	mutagenic	potential	of	crossover	events	that	are	
not	suppressed	anymore	by	RECQ5.	Consistent	with	this,	 it	has	been	shown	that	 in	human	





RECQ5-/-	 cells	with	MMC,	which	 induces	 interstrand	crosslinks,	disappeared	slower	 than	 in	
wild	type	cells	demonstrating	that	RECQ5	plays	a	role	in	RAD51	filament	dynamics	[240].		
In	 collaboration	with	Prof.	 Eli	 Rothenberg’s	 lab,	we	proposed	 a	model	 for	 how	 the	
different	 BLM	 domains	 interact	 with	 the	 G4-quadruplex	 and	 lead	 to	 its	 unwinding	 to	
preserve	 the	 telomere	 structure.	 Such	 G4-elements	 can	 also	 be	 found	 adjacent	 to	
transcription	 start	 sites	 where	 they	 interfere	with	 transcription	 [241].	 A	 recent	 study	 has	












To	 fight	 cancer	 and	 to	 identify	 new	 cancer	 therapy	 targets,	 it	 is	 absolutely	 necessary	 to	
understand	the	underlying	processes	and	the	key	players	that	lead	to	cancer	development.	
In	 this	work,	we	 provided	mechanistic	 insight	 into	DNA-end	 resection	 in	mammalian	 cells	
and	defined	WRN	as	a	new	crucial	 factor	participating	 in	this	process.	DNA	end	processing	
mediated	by	EXO1	is	regulated	by	cyclin-dependent	kinase		(CDK)	1	and		CDK2	in	human	cells	
[245].	 In	addition,	ATM	also	seems	to	play	a	role	 in	this	process	since	 its	 inhibition	caused	





mediate	 its	 recruitment	 to	broken	DNA	ends.	A	protein	 that	 is	 potentially	 involved	 in	 this	
process	could	be	RPA	since	it	has	been	shown	that	RPA	is	indispensable	for	Dna2	association	








Controlling	 of	 the	DNA2-mediated	 resection	 pathway	 in	 human	 cells	 could	 also	 be	
mediated	 via	 its	 interacting	 RecQ	 helicases	 that	 are	 crucial	 for	 the	 degradation	 of	 the	 5’	
terminated	 strand	by	DNA2,	namely	WRN	and	BLM.	Consistent	with	 this	hypothesis	 it	has	
been	 shown	 that	 acetylation	 and	 deacetylation	 of	 WRN	 plays	 a	 role	 in	 coordinating	 the	





its	 depletion	diminished	ATR	 activation	 after	 treating	 cells	with	 IR	 [252].	Within	 the	 same	
study	evidence	is	provided	that	DNA-end	resection,	which	is	a	prerequisite	for	HR	and	also	
ATR	 activation,	 was	 abrogated	 upon	 knockdown	 of	 TRF1	 [252].	 Taken	 together,	 although	
some	 proteins	 are	 known	 to	 be	 involved	 in	 the	 regulating	 system	 underlying	 DNA-end	
resection	 in	 human	 cells,	 the	 interplay	 between	 these	 factors	 during	 the	 cell	 cycle	 are	
somewhat	poorly	understood	and	thus	require	further	investigation.	
BLM	and	WRN	are	not	only	 involved	in	DNA-end	resection	but	also	 in	several	other	
processes	within	 the	 cell	 and	 are	potential	 targets	 for	 cancer	 therapy.	 In	 fact,	 it	 is	 known	
that	 WRN	 protein	 expression	 is	 upregulated	 in	 certain	 leukemia	 cancer	 types	 [253].	
Potentially,	 this	 increase	 in	 WRN	 expression	 arises	 because	 the	 high	 replicative	 state	 of	
cancer	cells	generates	lesions	in	the	DNA	that	have	to	be	repaired.	Evidence	that	targeting	
WRN	in	cancer	therapy	could	be	effective	comes	from	a	study	dealing	with	head	and	neck	
squamous	 cell	 carcinomas	 where	 it	 has	 been	 demonstrated	 that	 siRNA-mediated	
downregulation	of	WRN	impaired	tumour	cell	growth	[254].		
Since	WRN	and	BLM	are	involved	in	the	elimination	of	G4-quadruplexes.	It	would	be	
interesting	 to	 check	 whether	 WRN	 also	 plays	 a	 similar	 role	 like	 BLM	 in	 unwinding	 G4-
structures	 in	 promoters	 to	 allow	 gene	 expression.	 In	 addition,	 since	 G4-quadruplexes	 can	
also	 form	 at	 telomeres,	 one	 could	 combine	WRN	 or	 BLM	 inhibition	 with	 a	 G4-stabilizing	
agent	like	telomestatin	to	enhance	the	effect	on	cancer	cells.	Given	that	WRN	is	involved	in	
many	processes	of	cell	homeostasis,	 it	 is	an	attractive	target	 for	cancer	 therapy	and	 it	has	
already	 been	 shown	 that	 inhibition	 of	 its	 helicase	 function	 could	 be	 used	 to	 treat	 certain	
malignancies	[255].		
Our	 study	 showing	 that	 the	 mismatch-binding	 factor	 MutSβ	 can	 mediate	 ATR	
activation	 brings	 progress	 in	 understanding	 the	 signalling	 mechanisms	 that	 are	 initiated	
upon	DNA	DSB	induction.	It	would	be	interesting	to	define	the	control	mechanisms	in	human	
cells	that	lead	to	association	of	MutSβ	with	hairpin	loops	formed	in	RPA-coated	ssDNA.	The	









cell	 cycle	 progression.	 If	 this	mechanism	 is	 abolished,	 the	 checkpoint	 is	 not	 activated	 and	
hence	DNA	repair	is	affected	which	could	induce	lethal	effects	for	cancer	cells.		
The	 ATP-driven	 dissociation	 of	MutSβ	 from	RPA-coated	 ssDNA	 is	 likely	 to	 facilitate	
DNA	 repair.	 However,	 the	 molecular	 mechanism	 underlying	 the	 disassociation	 of	 MutSβ	
from	ssDNA	hairpin	loops	is	not	known.	To	further	explore	this	process,	mutant	versions	of	
MSH2	and	MSH3	in	their	ATPase	domains,	which	are	unable	to	bind	or	hydrolyse	ATP,	could	
be	generated.	These	mutants	 could	be	 tested	 for	 their	 ability	 to	bind	hairpin	 loops	within	
RPA-coated	ssDNA	to	define	the	exact	functions	of	ATP	binding	and	hydrolysis	by	MSH2	and	
MSH3	subunits	in	the	interaction	of	MutSβ	complex	with	ssDNA.		
In	 our	 study,	 we	 used	 CPT	 to	 induce	 replication-associated	 DNA	 DSBs.	 This	 drug	
treatment	caused	formation	of	numerous	DNA	DSBs	per	cell	generating	artificial	conditions	
where	 the	 amount	 of	 RPA	molecules	 is	 limited	 due	 to	 resection-dependent	 repair.	 Under	
such	 conditions,	 the	 formation	 of	 hairpin	 structures	within	 RPA-coated	 ssDNA	 could	 be	 a	
consequence	 of	 lack	 of	 RPA	 molecules	 leading	 to	 MutSβ-mediated	 ATR	 activation	 as	
described	 above.	 To	 test	 whether	 these	 hairpin	 structures	 do	 also	 persist	 under	 more	
physiological	 conditions,	 one	 could	 use	 cell	 lines	 carrying	 chromosomally-based	 DNA	 DSB	




towards	 the	 SDSA	 pathway	 and	 thus	 is	 important	 to	 prevent	 the	 formation	 of	 potentially	
mutagenic	crossovers.	Although	HR	is	limited	to	S	and	G2	phases	of	the	cell	cycle	and	DNA-
end	resection	is	a	prerequisite	for	this	pathway,	it	has	been	shown	that	resection	also	occurs	
during	M	phase	 [257].	 Since	 the	 end	processing	mechanism	within	 this	 cell	 cycle	 phase	 is	
only	 dependent	 on	 MRN/CtIP,	 it	 is	 highly	 likely	 that	 it	 is	 not	 very	 extensive	 [257].	
Nevertheless,	 RAD51	 could	 be	 loaded	 and	 perform	 homology	 search	 that	 would	 lead	 to	
entangled	 chromosomes,	 which	 would	 interfere	 with	 chromosome	 segregation.	
Interestingly,	 it	 has	 been	 shown	 that	 Rad51	 binding	 to	 RPA-coated	 ssDNA	 in	 M-Phase	 is	




filament	 assembly	 in	 human	 cells.	 Interestingly	 data	 obtained	 in	 our	 lab	 by	 Jana	 Langhoff	
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